Rifamycin Antibacterial [EPC]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Rifamycin Antibacterial [EPC] includes 2 drugs with a combined 27,208 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
27,208
Combined Reports
All Rifamycin Antibacterial [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| RIFAXIMIN | XIFAXAN | 13,861 | 5,009 | 4,847 | 36.1% |
| RIFAMPIN | Rifampin | 13,347 | 1,439 | 5,764 | 10.8% |
Common Side Effects in Rifamycin Antibacterial [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Death | 3,828 | 3,822 |
| Drug ineffective | 1,674 | 356 |
| Hospitalisation | 1,634 | 199 |
| Off label use | 1,442 | 122 |
| Drug reaction with eosinophilia and systemic symptoms | 1,057 | 53 |
| Diarrhoea | 1,018 | 87 |
| Condition aggravated | 1,017 | 126 |
| Nausea | 967 | 36 |
| Product use in unapproved indication | 920 | 63 |
| Therapy interrupted | 882 | 163 |